2,034 results on '"Schalkwijk, Casper"'
Search Results
52. Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose-induced non-alcoholic fatty liver disease
53. Associations of dicarbonyl stress with complement activation: the CODAM study
54. Epigenome-wide Association Study of Attention-Deficit/Hyperactivity Disorder Symptoms in Adults
55. Adipose tissue macrophages do not affect atherosclerosis development in mice
56. Moderate-Intensity and High-Intensity Interval Exercise Training Offer Equal Cardioprotection, with Different Mechanisms, during the Development of Type 2 Diabetes in Rats.
57. GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
58. FRI615 The 1-Hour OGTT Plasma Glucose As A Biomarker Of β-cell Function
59. 47 Plasma factor D cross-sectionally associates with low-grade inflammation, endothelial dysfunction and cardiovascular disease, but not with intima-media thickness or ankle-brachial index: The Maastricht Study
60. A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial
61. Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study
62. Circulating Polyunsaturated Fatty Acids as Biomarkers for Dietary Intake across Subgroups : The CODAM and Hoorn Studies
63. HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men
64. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study
65. Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study
66. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis
67. Associations of Arterial Stiffness With Cognitive Performance, and the Role of Microvascular Dysfunction: The Maastricht Study
68. Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study
69. Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study
70. Corrigendum to “The cardiometabolic depression subtype and its association with clinical characteristics: The Maastricht Study” [J. Affect. Disord. 313 (2022) 110–117]
71. Diet-induced weight loss improves not only cardiometabolic risk markers but also markers of vascular function: a randomized controlled trial in abdominally obese men
72. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer
73. Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study.
74. Blood pressure variability and microvascular dysfunction: the Maastricht Study
75. Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study
76. YI 2.3 Methylglyoxal, 3-Deoxyglucosone, and Glyoxal – Precursors of Advanced Glycation Endproducts – are not Independently Associated with Indices of Carotid Stiffness: The Maastricht Study
77. The effect of Mindfulness-Based Stress Reduction on wound healing: a preliminary study
78. Circulating and adipose tissue immune cells in tissue‐specific insulin resistance in humans with overweight and obesity
79. Comment on Lee et al. Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care 2022;45:1917–1930
80. Plasma Advanced Glycation Endproducts and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
81. Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double‐blind placebo‐controlled trial
82. Far infrared treatment on the arteriovenous fistula induces changes in sVCAM and sICAM in patients on hemodialysis
83. Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo– The Maastricht Study
84. Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice
85. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort
86. Circulating and adipose tissue immune cells in tissue-specific insulin resistance in humans with overweight and obesity
87. Plasma Advanced Glycation End Products and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
88. Far infrared treatment on the arteriovenous fistula induces changes in sVCAM and sICAM in patients on hemodialysis
89. Depression and markers of inflammation as predictors of all-cause mortality in heart failure
90. Associations of low grade inflammation and endothelial dysfunction with depression – The Maastricht Study
91. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial1–3
92. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria
93. Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database
94. Association of Type D personality with increased vulnerability to depression: Is there a role for inflammation or endothelial dysfunction? – The Maastricht Study
95. Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study
96. Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease
97. Increased methylglyoxal formation in plasma and tissues during a glucose tolerance test is derived from exogenous glucose
98. Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal
99. Atrial Fibrillation Coincides with the Advanced Glycation End Product Nε-(Carboxymethyl)Lysine in the Atrium
100. The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.